Pharmacology
Conference Coverage
Hypertension worsened by commonly used prescription meds
Close to 20% of U.S. adults with hypertension are on a prescription drug, such as NSAIDs, known to raise blood pressure, creating an opportunity...
News
Exercise plus liraglutide better for maintaining weight loss than either strategy alone
Study findings also support the feasibility of moderate to vigorous exercise interventions even in individuals with obesity who had a very low...
News
FDA approves dapagliflozin (Farxiga) for chronic kidney disease
Based on results of the DAPA-CKD trial, the FDA has granted approval for the diabetes drug in patients with CKD at risk for disease progression....
News
FDA OKs higher-dose naloxone nasal spray for opioid overdose
Kloxxado delivers 8 mg of naloxone into the nasal cavity, which is twice as much as the 4 mg of naloxone contained in Narcan.
News
The cloudy role of cannabis as a neuropsychiatric treatment
Medical cannabis has been made widely available to patients and has largely outpaced the clinical evidence.
Conference Coverage
Superior survival with sintilimab in squamous NSCLC
Sintilimab improved overall and progression-free survival, when compared with docetaxel.
Latest News
Pfizer developing pill to treat COVID-19 symptoms
An oral drug could be taken at home and might keep people out of the hospital.
Conference Coverage
Some MS treatments may heighten COVID risk
An Italian registry shows worse outcomes with anti-CD20 treatment, but a possible protective effect of interferon and teriflunomide.
Conference Coverage
Line of therapy matters for assessing biologic’s serious infection risk in RA
The risk for serious infection seen with tocilizumab is confounded by whether the drug is given as first-line or as subsequent treatment in the...
News
Survival benefit with nivolumab extends to 5 years in NSCLC
Early response portends durable outcome, but the optimal duration of treatment is uncertain.